Parkinson's: It Started With a Gut Feeling
When neuroanatomists proposed a new theory on the origin and progression of Parkinson’s disease, they started a debate in the field...
6397 RESULTS
Sort By:
When neuroanatomists proposed a new theory on the origin and progression of Parkinson’s disease, they started a debate in the field...
Uppsala: Conference Puts Uppsala on Immunotherapy Map Uppsala: Is Tau Immunotherapy Taking Off? Uppsala: Immunotherapy—Not Just for AD Anymore Science has come a long way since botanist Carl Linnaeus built his catalogue and plant extracts were the medicin
As immune-based therapies targeting Aβ and tau are beginning to show promise for the treatment of Alzheimer’s, what about other disorders of the nervous system?...
Effective cell replacement therapy for Parkinson’s disease has been an elusive target...
Sometimes a fresh pair of eyes can see new pathways to solve a problem...
When an anatomist first proposed that Parkinson’s disease begins in the gut, then slowly makes its way to the brain, his idea might have sounded like fiction...
Researchers showed that memory consolidation in the cortex can occur within 48 hours if the new information fits into an existing mental schema...
Pericyte-enwrapping blood vessels near a spinal lesion will differentiate and move toward the injury, forming the core of an astrocyte-coated scar...
New research points to two potential approaches for attacking PD—one going after a well-known culprit, the other targeting an up-and-coming one...
A paper in today’s Nature Neuroscience contends that Aβ43 can play a major role in pathology...
Genetics may play a bigger role in Parkinson's disease than previously appreciated...
Aging and dementia are typically associated with off-kilter circadian rhythms, with more than 80 percent of the 65-plus age bracket suffering sleep problems...
Having established the first 42 amino acids in Aβ as a valid biomarker for AD, researchers are now turning their attention to all the other fragments of APP in the CSF...
Targeting extracellular Aβ with immunotherapy is one thing, but could antibodies even drive the clearance of tau, a predominantly intracellular protein?...
Data suggest that ApoE variants contribute to risk for AD by affecting the peptide’s clearance from the brain long before amyloid deposition begins...
No filters selected